Determination of activation products and resulting decommissioning implications for the Varian TruBeam linear accelerator - Paper 52
Modern medical linear accelerators used for the treatment of cancers are capable of operating at electron energies as high as 20 MeV. Above electron energies of 6 MeV, a measurable dose rate is obtained at the isocenter after beam termination. This is attributed to the activation of linear accelerator components through photonuclear reactions and neutron capture. Photons are produced as Bremsstrahlung during the collision of high-energy electrons with a heavy metal target, typically comprised of copper or tungsten. When photons exceeding the nucleon binding energy interact with a nucleus, neutrons are ejected. In the process of neutron capture, neutrons produced through ({gamma}, n) reactions are absorbed by a nucleus and the excess energy is emitted as a photon. Over the lifetime of an accelerator many components, such as the target, flattening filter, collimators, jaws, and treatment couch, are activated through these interactions. Although dependent on operating conditions, linear accelerators have an expected lifetime of 7 to 10 years. In Canada, at the end of their service, accelerators are typically sold for scrap, returned to a remanufacturing enterprise, or if the machine is still operational it can be retasked for continued use. Since many of the accelerator components have been exposed to a neutron fluence and activated to various extents, the requirements of the Canadian Nuclear Substance and Radiation Device regulations apply prior to final removal from the hospital. For shipments to the USA, there are exemption regulations to be considered. NRC regulation 10CFR 30.71 Schedule B lists a number of common radionuclides and the specific exemption quantity. Below these levels, radioactive materials may be freely transported from Canada to the USA without prior licensing from the Canadian Nuclear Safety Commission (CNSC) or United States Nuclear Regulatory Commission (NRC). (authors)